ArticleSAGE open nursing
Acceptance Rate of Index Case Human Immunodeficiency Virus Testing and its Associated Factors Among Patients Receiving Anti-retroviral Therapy in a Public Health Facilities in Arba Minch Town, Southern Ethiopia.
Article in SAGE open nursing. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Index case human immunodeficiency virus (HIV) testing is a key strategy to identify those most at risk of acquiring HIV, with a high yield of positive cases. Objective: To assess the acceptance rate of index case HIV testing and its associated factors among patients receiving anti-retroviral therapy in a public health facility in Arba Minch town, Southern Ethiopia, 2024. Methods: A facility-based, retrospective study was conducted from July 1 to 15, 2024. The total sample size was 379, and a simple random sampling technique was used to select clients' cards. Data were entered into Epi Data version 3.1 and then exported to statistical package for social science version 25 statistical software for analysis. Binary logistic regression analysis was used to check the association. Finally, significant independent associations were identified with a p-value less than 0.05 and a 95% confidence interval (CI). Result: The acceptance of index case HIV testing among patients on anti-retroviral therapy follow-up was 72.8% with a 95% CI (68.6-77.4). Gender [adjusted odds ratio (AOR): 2.69, 95%CI: 1.46-5.37], place of residence [AOR: 2.35, 95%CI: 1.26-4.39], WHO clinical stage I [AOR: 0.07, 95%CI: 0.01-0.59], WHO clinical stage II [AOR: 0.09, 95%CI: 0.01-0.89], duration on ART [AOR: 2.61, 95%CI: 1.23-5.55], disclosure status [AOR: 5.53, 95%CI: 2.87-10.65], and educational status of the partner [AOR: 0.12, 95%CI: 0.04-0.44] were associated. Conclusion: Seven in 10 patients on anti-retroviral therapy follow-up accept index case HIV testing. Gender, place of residence, WHO clinical stage, duration of anti-retroviral therapy, exposure status, and spouse education were associated with HIV testing acceptance. Thus, gender identity, urbanization of the index case location, description of the index case at the WHO clinic level, reporting of cases to household members, and improving spouse education would increase acceptance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.